Generation of an Apoptotic Intracellular Peptide by γ-Secretase Cleavage of Alzheimer's Amyloid ß Protein Precursor

Brent J. Passer(National Institute of Allergy and Infectious Diseases), Luca Pellegrini(National Institute of Allergy and Infectious Diseases), Claudio Russo(University of Genoa), Richard M. Siegel(National Institutes of Health), Michael J. Lenardo(National Institute of Allergy and Infectious Diseases), Gennaro Schettini(University of Genoa), Martin F. Bachmann(ETH Zurich), Massimo Tabaton(University of Genoa), Luciano D'adamio(National Institute of Allergy and Infectious Diseases)
Journal of Alzheimer s Disease
October 1, 2000
Cited by 200

Abstract

The amyloid beta protein precursor (AbetaPP) is sequentially processed by beta- and gamma-secretases to generate the Abeta peptide. The biochemical path leading to Abeta formation has been extensively studied since extracellular aggregates of amyloidogenic forms of Abeta peptide (Abeta42) are considered the culprit of Alzheimer's disease. Aside from its pathological relevance, the biological role of AbetaPP proteolysis is unknown. Although never previously described, cleavage of AbetaPP by gamma-secretase should release, together with Abeta, a COOH-terminal AbetaPP Intracellular Domain, herein termed AID. We have now identified AID-like peptides in brain tissue of normal control and patients with sporadic Alzheimer's disease and demonstrate that AID acts as a positive regulator of apoptosis. Thus, overproduction of AID may add to the toxic effect of Abeta42 aggregates and further accelerate neurodegeneration.


Related Papers

No related papers found

Powered by citation graph analysis